An Analysis of the Inclusion of Ear and Hearing Care in National Health Policies, Strategies, and Plans.
Julia CanickBeatriz PetrucciRolvix PattersonJames SaundersMay Htoo ThawIkeoluwa OmosuleAlexa DentonMary Jue XuShelly ChadhaGabrielle YoungLyna SiafaOlivier MortelAlizeh ShamshadAshwin ReddyMonet McCallaKavita PrasadHong-Ho YangDebbie R PanJaffer ShahEmily SmithBlake AlkireTitus IbekweChristopher James WaterworthPublished in: Health policy and planning (2023)
Ear and hearing-related conditions pose a significant global health burden, yet public health policy surrounding ear and hearing care (EHC) in low- and middle-income countries is poorly understood. The present study aims to characterize the inclusion of EHC in national health policy by analyzing National Health Policies, Strategies, and Plans in English, French, Spanish, Portuguese, and Arabic. Three ear and hearing care keywords were searched, including ear*, hear*, and deaf*. The terms "HIV/AIDS," "tuberculosis," and "malaria" were included as comparison keywords as these conditions have historically garnered political priority in global health. Of the 194 World Health Organization member states, there were 100 national policies that met inclusion criteria of document availability, searchable format, language, and absence of an associated national EHC strategy. These documents mentioned EHC keywords significantly less than comparison terms, with mention of hearing in 15 documents, ears in 11 documents, and deafness in 3 documents. There was mention of HIV/AIDS in 92 documents, tuberculosis in 88 documents, and malaria in 70 documents. Documents in low- and middle-income countries included significantly fewer mentions of EHC terms than those of high-income countries. We conclude that ear and hearing conditions pose a significant burden of disease but are severely underrepresented in national health policy, especially in low- and middle-income countries.
Keyphrases
- public health
- global health
- hiv aids
- healthcare
- hearing loss
- quality improvement
- antiretroviral therapy
- palliative care
- mental health
- pain management
- human immunodeficiency virus
- mycobacterium tuberculosis
- physical activity
- hiv infected
- autism spectrum disorder
- tyrosine kinase
- hepatitis c virus
- affordable care act
- health insurance
- drug induced
- adverse drug